PTGX
Protagonist Therapeutics, Inc. - Common Stock NASDAQ
Last close
$139.91
as of 08 Oct 2026
- Avg call return
- −4.0%
- −4.5% vs. index
- Scored calls
- 1
- Channels
- 1
- Win Rate
- 0%
- Side taken
- 1Buy 0Sell
1 scored calls · 1 channels · first tracked 04 Sep 2026
PTGX: tracked call record. Across the full tracked record, 1 of 1 published calls are scored, with an average call return of -3.99%. Scored calls were published from 04 Sep 2026 to 04 Sep 2026, measured from each entry price to its latest available close (price dates: 08 Oct 2026 to 08 Oct 2026). Average benchmark excess is -4.47 percentage points, based on 1 of the 1 scored calls only. Unscored calls are excluded from averages. Holding periods and price freshness vary. These are averages of directional call returns, not an investable portfolio return; fees, dividends and execution costs are not included.
Who is calling PTGX
Last 12 months · 1 buying · 0 selling
-
01
Dylan Rieger Buy Calls 1 Return −4.0% Show calls
-
04 Sep 2026
Buy
Entry
$145.72
Now
$139.91
−4.0%
vs. index
−4.5%
AI-extracted call. Cite this call
I like PTGX because it still offers good upside, but it is a much more validated story than a speculative biotech with no approved products.
-
04 Sep 2026
Buy
Entry
$145.72
Now
$139.91
−4.0%
vs. index
−4.5%
Every video calling PTGX
Understand these figures or report an error: Methodology Corrections policy